BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferretti F, Cannatelli R, Benucci M, Carmagnola S, Clementi E, Danelli P, Dilillo D, Fiorina P, Galli M, Gallieni M, Genovese G, Giorgi V, Invernizzi A, Maconi G, Maier JA, Marzano AV, Morpurgo PS, Nebuloni M, Radovanovic D, Riva A, Rizzardini G, Sabiu G, Santus P, Staurenghi G, Zuccotti G, Sarzi-Puttini PC, Ardizzone S. How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group. Front Immunol 2021;12:656362. [PMID: 33936084 DOI: 10.3389/fimmu.2021.656362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Invernizzi A. The impact of COVID-19 on the retina: clinical features and management considerations. Expert Review of Ophthalmology. [DOI: 10.1080/17469899.2022.2021877] [Reference Citation Analysis]
2 Papasavvas I, Herbort CP Jr. Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination. J Ophthalmic Inflamm Infect 2021;11:21. [PMID: 34224024 DOI: 10.1186/s12348-021-00251-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
3 Toscano S, Chisari CG, Patti F. Multiple Sclerosis, COVID-19 and Vaccines: Making the Point. Neurol Ther 2021;10:627-49. [PMID: 34625925 DOI: 10.1007/s40120-021-00288-7] [Reference Citation Analysis]
4 D'Amelio R, Asero R, Cassatella MA, Laganà B, Lunardi C, Migliorini P, Nisini R, Parronchi P, Quinti I, Racanelli V, Senna G, Vacca A, Maggi E. Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies. Biomedicines 2021;9:1163. [PMID: 34572349 DOI: 10.3390/biomedicines9091163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Elkharsawi A, Arnim UV, Schmelz R, Sander C, Stallmach A, Teich N, Walldorf J, Reuken PA. SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease. Z Gastroenterol 2022;60:77-80. [PMID: 35042256 DOI: 10.1055/a-1710-3861] [Reference Citation Analysis]
6 Cannatelli R, Ferretti F, Carmagnola S, Bergna IMB, Monico MC, Maconi G, Ardizzone S. Risk of adverse events and reported clinical relapse after COVID-19 vaccination in patients with IBD. Gut 2021:gutjnl-2021-326237. [PMID: 34819330 DOI: 10.1136/gutjnl-2021-326237] [Reference Citation Analysis]
7 Gambichler T, Boms S, Susok L, Dickel H, Finis C, Abu Rached N, Barras M, Stücker M, Kasakovski D. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol 2021. [PMID: 34661927 DOI: 10.1111/jdv.17744] [Reference Citation Analysis]
8 Momenaei B, Cheraqpour K, Soleimani M, Tabatabaei SA, Shahriari M, Etesali H, Hussein A, Vaseghi Y, Ramezani B, Djalilian AR. Ophthalmic side effects of COVID-19 vaccines. Expert Review of Ophthalmology. [DOI: 10.1080/17469899.2022.2066523] [Reference Citation Analysis]
9 Prabhu MM, Palaian S, Ansari M. Safety profile of COVID-19 vaccines, preventive strategies and patient management. Expert Rev Vaccines 2022. [PMID: 35559718 DOI: 10.1080/14760584.2022.2078311] [Reference Citation Analysis]